---

Dexmedetomidine — Comprehensive Overview

---

1. Mechanism of Action

• Sedation/hypnosis: via α₂ receptors in the locus coeruleus → activates endogenous sleep pathways, producing a state resembling physiologic NREM sleep
• Analgesia: via α₂ receptors at the spinal cord level (dorsal horn)
• Sympatholysis: reduces central noradrenergic outflow → decreased heart rate, BP, and plasma catecholamines
• Its effects are reversible with α₂-antagonists (e.g., atipamezole)

---

2. Pharmacokinetics

---

3. Organ System Effects

CNS

• Sedation resembling natural sleep — patients are arousable and cooperative
• Anxiolysis, mild analgesia
• Minimal amnesia (vs. benzodiazepines)
• ↓ cerebral blood flow (CBF ~25%), without significant change in ICP or CMRO₂
• Potential for tolerance and dependence with prolonged use
• Anti-shivering properties (via α₂ activation in thermoregulatory center)

Cardiovascular

• Loading bolus: transient ↑ BP (peripheral α₂ vasoconstriction) → followed by ↓ HR (reflex + central vagal predominance)
• Infusion: ↓ HR, ↓ SVR, ↓ BP (moderate)
• Risk of severe bradycardia, heart block, sinus arrest — especially when combined with sympatholytic or vagotonic agents (e.g., neostigmine, β-blockers, digoxin)
• Response to atropine/anticholinergics is preserved

Respiratory

• Minimal respiratory depression — ventilatory response to CO₂ unchanged
• Small ↓ tidal volume, essentially no change in RR
• Upper airway obstruction can occur with deep sedation
• Preserves spontaneous respiration even at high doses (key advantage)
• Synergistic sedation when combined with other sedative-hypnotics

---

4. Clinical Uses

ICU Sedation (Primary Indication)

• First-line for short-term sedation of intubated/ventilated ICU patients
• Advantages over benzodiazepines:
  • ↓ duration of mechanical ventilation
  • ↑ patient comfort
  • ↓ incidence and duration of perioperative delirium
  • More cooperative behavior ("cooperative sedation")

Monitored Anesthesia Care (MAC) / Procedural Sedation

• Useful for awake fiberoptic intubation — cooperative, comfortable patient + dry mouth effect
• Painful procedures — analgesic properties supplement sedation
• Lower legislative restrictions vs. propofol in some jurisdictions

Adjunct to General Anesthesia

• Reduces requirements for inhaled and IV anesthetics
• Dose: 0.5–1 mcg/kg loading over 10–15 min → infusion 0.2–0.7 mcg/kg/h
• Preoperative dexmedetomidine reduces fentanyl consumption in abdominal, cholecystectomy, and intraocular surgery
• Smooth emergence; sedative + analgesic effects persist into PACU without respiratory depression

Pediatrics (off-label)

• Intranasal dexmedetomidine 1 mcg/kg — preoperative anxiolysis
• ICU sedation in children
• Arousability preserved; sedation resembles natural sleep

Regional Anesthesia Adjunct

• Perineural injection as adjunct to brachial plexus block — may extend duration (evidence limited, not statistically significant in all studies)

---

5. Dosing

---

6. Adverse Effects & Contraindications

• Hypotension — most common; can persist for hours (limits PACU discharge)
• Bradycardia / Heart block / Sinus arrest — especially with vagotonic co-medications
• Transient hypertension with rapid bolus
• Dry mouth
• Tolerance/dependence with prolonged infusion

• Sympatholytic agents (β-blockers, clonidine)
• Cholinergic agents (neostigmine, physostigmine)
• Other sedatives (synergistic respiratory depression risk)

• Advanced heart block or sick sinus syndrome (without pacemaker)
• Severe hepatic impairment (↓ clearance)
• Renal impairment (↑ duration of effect)
• Hypovolemia

---

7. Dexmedetomidine in Muscular Dystrophy (MD) Context

• Avoids triggering malignant hyperthermia — unlike volatile agents and succinylcholine, which are contraindicated in Duchenne/Becker MD
• Preserves respiratory function — critical in patients with MD-related respiratory muscle weakness
• Cardiac safety: MD patients often have cardiomyopathy — dexmedetomidine's sympatholytic effect reduces myocardial oxygen demand, but its bradycardia risk requires careful monitoring
• One published case (PMID 38855294, 2024) describes combined general + regional anesthesia in a Duchenne MD patient with LVAD undergoing orthopedic surgery, where careful agent selection (avoiding triggers) was essential

---

Summary

---

Double-Lumen Endotracheal Tube (DLT)

---

1. Design & Structure

• Tracheal cuff — proximal, seals the trachea
• Bronchial cuff (typically colored blue) — distal, seals the intubated bronchus

• Left-sided DLT — bronchial lumen goes into the left mainstem bronchus (preferred for most cases)
• Right-sided DLT — bronchial lumen goes into the right mainstem bronchus; has a ventilation slot to preserve right upper lobe (RUL) ventilation

---

2. Indications

Absolute Indications (lung isolation mandatory)

• Protection of the healthy lung from contamination (e.g., massive hemoptysis, lung abscess, empyema, bronchopleural fistula)
• Unilateral pulmonary lavage (e.g., pulmonary alveolar proteinosis)
• Large bronchopleural or bronchopleural-cutaneous fistula
• Life-threatening hemorrhage from one lung

Relative Indications (surgical access)

• Thoracic aortic aneurysm repair
• Pneumonectomy, lobectomy, segmentectomy
• Esophageal surgery
• Thoracoscopy (VATS)
• Bilateral sympathectomy / bilateral procedures requiring independent lung ventilation
• Single lung transplantation

---

3. Left vs. Right DLT — Which to Use?

Indications for a Right-Sided DLT

---

4. Size Selection

---

5. Insertion Technique

1. Laryngoscopy — MacIntosh (curved) blade preferred; provides more room to maneuver the large tube. Video laryngoscopy is also acceptable.
2. Pass the DLT with the distal curvature concave anteriorly.
3. Once the bronchial cuff clears the vocal cords, rotate 90° toward the target bronchus (counterclockwise for left-sided placement).
4. Advance until resistance is felt (average depth ~29 cm at teeth) or advance over a fiberoptic bronchoscope placed through the bronchial lumen.
5. Do not force — the cricoid ring diameter approximates the left mainstem bronchus diameter and is the narrowest point.

---

6. Confirming Position — Clinical Protocol (Left-Sided DLT)

1. Inflate tracheal cuff (5–10 mL) → check for bilateral breath sounds
   • Unilateral = tube too far down
2. Inflate bronchial cuff (1–2 mL)
3. Clamp tracheal lumen → ventilate via bronchial lumen
   • Should hear left-sided only breath sounds
   • If right-sided sounds persist → bronchial opening still in trachea → advance tube
   • If right-sided only → tube in right bronchus → reposition
   • If left upper lobe silent → tube too far down left bronchus → withdraw
4. Unclamp tracheal, clamp bronchial lumen → ventilate via tracheal lumen
   • Should hear right-sided breath sounds
   • Absent/diminished = bronchial cuff occluding distal trachea → withdraw

• Through tracheal lumen: carina visible; bronchial lumen entering left bronchus; blue bronchial cuff 5–10 mm below carina in left bronchus, not herniating over carina
• Through bronchial lumen: patent; left upper and lower lobe orifices visible

• Through right-sided DLT bronchial lumen: confirm RUL ventilation slot aligns with RUL orifice
• Re-confirm position after repositioning patient to lateral decubitus (tube can migrate)

---

7. Malposition Problems (6 Types)

---

8. DLT vs. Bronchial Blocker (BB) — Comparison

---

9. One-Lung Ventilation (OLV) After DLT Placement

• Patient in lateral decubitus — operative ("up") lung isolated/collapsed; ventilated ("down") lung is dependent
• Start with FiO₂ 1.0 during OLV for safety margin
• Tidal volume: 5–6 mL/kg (lung-protective)
• Apply PEEP 5 cmH₂O to dependent lung
• If hypoxemia: apply CPAP 5–10 cmH₂O to non-dependent lung, or recruit dependent lung

---

---

Permissive Hypercapnia

---

1. Definition

"Permissive hypercapnia accepts the consequences of deliberate hypoventilation to prioritize reduction of alveolar overdistension and airway pressures in patients with poor lung compliance." — Current Surgical Therapy, 14th ed.

---

2. Physiologic Rationale — Why Allow Hypercapnia?

The Problem: VILI

• Volutrauma — alveolar overdistension from excessive volume
• Barotrauma — injury from high airway pressures (plateau pressure >30 cmH₂O)
• Atelectrauma — cyclic alveolar collapse and reopening with each breath
• Biotrauma — inflammatory mediator release triggering systemic injury

The Solution: Low Tidal Volume Ventilation

---

3. CO₂ Targets & pH Thresholds

• Gradual hypercapnia produces less severe acidemia than acute CO₂ elevation because renal compensation has time to partially buffer the pH
• pH <7.15 generally warrants intervention
• If renal compensation is inadequate: NaHCO₃ infusion or THAM (tromethamine) may be used — though evidence for their benefit is uncertain

"Most critical care practitioners adopt a pragmatic approach... targeting a pH greater than 7.25." — Miller's Anesthesia, 10th ed.

---

4. Clinical Indications

---

5. Physiologic Effects of Hypercapnia

Potentially Protective

• Attenuates free radical–mediated lung injury (antioxidant effect at tissue level)
• Reduces pulmonary inflammation
• Vasodilatory effect on systemic vasculature
• Shifts oxygen–haemoglobin dissociation curve rightward (Bohr effect) → ↑ O₂ delivery to tissues

Potentially Harmful

"The magnitude of the acidaemia associated with permissive hypercapnia may be augmented if superimposed on metabolic acidosis, such as lactic acidosis. This combination is not uncommon in the critical care unit." — Brenner & Rector's The Kidney

---

6. Contraindications / Use with Caution

---

7. Management of Acidosis During PHC

1. Sodium bicarbonate (NaHCO₃) — IV infusion; commonly used, though evidence is uncertain; gives CO₂ as byproduct (must be able to exhale it)
2. THAM (tromethamine) — buffers CO₂ without generating additional CO₂; useful when CO₂ elimination is impaired
3. Goal: bring pH to ≥7.15–7.25, not to normalize bicarbonate or pH completely

---

8. Alternatives to Minimize Hypercapnia (When PHC Poorly Tolerated)

"Although permissive hypercapnia was previously thought to be benign, it has several physiologic consequences, and alternative interventions, including prone ventilation, ultralow tidal volume ventilation, ECMO, and ECCO₂R, are being used to minimize hypercapnia or even aim for normocapnia." — Comprehensive Clinical Nephrology, 7th ed.

---

9. Key Evidence

• ARDSNet (ARMA) trial — The landmark RCT showing 22% relative mortality reduction with VT 6 mL/kg IBW vs 12 mL/kg in ARDS. Notably, this trial treated respiratory acidosis aggressively (increased RR up to 35/min, used NaHCO₃); it did not deliberately pursue hypercapnia.
• The original pilot studies by Hickling et al. (1994) reported low mortality using low-volume, pressure-limited ventilation with PHC, providing the conceptual foundation.
• Uncertainty remains about whether hypercapnia itself is beneficial, harmful, or neutral — current evidence supports tolerating it as a side effect of lung-protective ventilation, not actively targeting it.

"Given the uncertainty about permissive hypercapnia, the original ARDSNet trial... treated respiratory acidosis aggressively. In the absence of other data, avoidance of hypercapnia where possible seems prudent." — Murray & Nadel's Respiratory Medicine

---

Summary

---

Positive End-Expiratory Pressure (PEEP)

---

1. Definition

• PEEP — positive end-expiratory pressure applied during mechanical (ventilator-cycled) breaths
• CPAP — continuous positive pressure applied during spontaneous breathing (invasive or noninvasive)
• In clinical practice the terms are often used interchangeably since most modern ventilators deliver a combination; strictly speaking they differ in whether breathing is controlled or spontaneous

---

2. Physiologic Effects

A. Pulmonary Effects

"The major effect of PEEP and CPAP on the lungs is to increase FRC. In patients with decreased lung volume, appropriate levels will increase FRC and tidal ventilation above closing capacity, improve lung compliance, and correct ventilation/perfusion abnormalities." — Morgan & Mikhail, 7th ed.

• PEEP does not uniformly recruit all lung units; it can overdistend well-aerated (non-dependent) regions while potentially failing to recruit collapsed dependent zones
• This is particularly relevant in focal lung disease (e.g., lobar pneumonia) where PEEP may simply over-distend healthy regions and worsen V/Q mismatch
• PEEP is most effective in diffuse parenchymal disease (ARDS, pulmonary edema)

B. Cardiovascular Effects

"The major risks of PEEP are overdistention of the lung and hemodynamic consequences, such as decreasing cardiac output by decreasing venous return or increasing right ventricular afterload." — Goldman-Cecil Medicine

C. CNS Effects

• High PEEP → ↑ intrathoracic pressure → impedes cerebral venous drainage → ↑ ICP
• The "optimal PEEP for oxygenation may be the worst PEEP for cerebral venous drainage"

---

3. Indications

---

4. PEEP Settings & Titration

Routine / Physiologic PEEP

• 5–8 cmH₂O routinely added to all mechanically ventilated patients to preserve FRC and compensate for the loss of intrinsic glottic PEEP (~3–5 cmH₂O) that normally exists in spontaneously breathing patients

In ARDS — ARDSNet FiO₂/PEEP Tables

Titration Methods

• Increase PEEP in steps → observe plateau pressure
• When plateau pressure stops increasing (lung is optimally recruited), peak and plateau may actually decrease as more lung volume is available
• Once plateau pressure rises disproportionately beyond the PEEP increment → overdistension; reduce PEEP

• After recruitment maneuver, set PEEP to 20–25 cmH₂O
• Decrease PEEP stepwise; select PEEP that maximizes respiratory system compliance (ΔP = driving pressure = Pplat – PEEP)
• Promising physiologically but the largest RCT (ART trial, 2017) showed increased 28-day mortality with aggressive recruitment + compliance-titrated PEEP → now discouraged for routine use

• Lower inflection point (LIP) on P-V curve = pressure at which collapsed alveoli begin recruiting
• Set PEEP above LIP to keep recruited alveoli open
• Upper inflection point = overdistension threshold; keep plateau below it

• Esophageal pressure ≈ pleural pressure; transpulmonary pressure = airway pressure − esophageal pressure
• Useful in obese patients, ascites, chest wall edema where chest wall compliance is reduced (allows higher PEEP safely)
• Large RCT (EPVent-2) showed no mortality difference vs. empiric PEEP — not standard practice

• Increase PEEP until: (a) PaO₂ ceases to improve, (b) CO₂ rises (overdistension sign), or (c) BP drops
• Reduce if complications emerge; volume-resuscitate if hemodynamics limit the desired PEEP

"Optimal PEEP can be determined... the clini cian must readily identify the plateau in the plateau pressure trend." — Roberts & Hedges' Clinical Procedures in Emergency

---

5. Intrinsic PEEP (Auto-PEEP / iPEEP)

Causes

• Obstructive disease (asthma, COPD) — high airway resistance + high compliance = long expiratory time constant (τ = R × C)
• Short expiratory time — high RR, high I:E ratio, large VT
• Dynamic airway collapse — expiratory flow limitation even with adequate time

• ~3 time constants needed for complete exhalation
• Example: R = 10 cmH₂O/L/s, C = 0.05 L/cmH₂O → τ = 0.5 s → needs ~1.5 s to empty

Detection

• Flow-time curve: expiratory flow does not return to zero before the next breath
• Expiratory hold maneuver: measure pressure during expiratory occlusion = total PEEP − set PEEP = iPEEP
• Clinical signs: unexpectedly ↑ airway pressures, ↓ compliance, hypotension

Consequences

• ↑ Intrathoracic pressure → ↓ venous return → hypotension / ↓ CO
• ↑ Work of breathing (patient must generate sufficient effort to overcome iPEEP before triggering the ventilator)
• Contributes to VILI (dynamic hyperinflation)
• Can cause hemodynamic collapse if severe (treat by briefly disconnecting from ventilator to allow full exhalation)

Management

• Reduce RR and/or VT
• Extend expiratory time (adjust I:E ratio → ≥1:3 or 1:4)
• Bronchodilators (↓ resistance)
• Apply external PEEP ≤ iPEEP to reduce inspiratory trigger threshold (makes triggering easier without ↑ end-expiratory lung volume)

"Theoretically, for the spontaneously breathing patient, extrinsic PEEP applied to counteract intrinsic PEEP should not cause an increase in EELV until extrinsic PEEP exceeds intrinsic PEEP." — Miller's Anesthesia, 10th ed.

---

6. Adverse Effects

---

7. Recruitment Maneuvers (RMs)

• Multiple RCTs show RMs + high PEEP improve oxygenation but do not reduce mortality in ARDS
• The ART trial (2017): aggressive RM + compliance-titrated PEEP → increased 28-day mortality — use with caution
• RMs are not benign: transient hypotension, desaturation, dyssynchrony, rare tension pneumothorax

"A more recent study... the group that received recruitment maneuvers and titrated PEEP displayed increased 28-day all-cause mortality." — Murray & Nadel's Respiratory Medicine

---

8. PEEP in Specific Contexts

---

Summary Table

---

Auto-PEEP (Intrinsic PEEP / Dynamic Hyperinflation)

---

1. Definition

"Auto-PEEP is defined as the difference between alveolar pressure and airway opening pressure at end expiration... associated with dynamic hyperinflation, which is an increase in the end-expiratory lung volume above the value that would be obtained if there was complete exhalation to the static FRC." — Goldman-Cecil Medicine

---

2. Pathophysiology

The Expiratory Time Constant

• Normal: R ≈ 5 cmH₂O/L/s, C ≈ 0.05 L/cmH₂O → τ = 0.25 s → needs ~0.75 s to fully empty
• COPD: R ↑↑, C ↑↑ → τ = 0.5–1.0 s+ → needs 1.5–3+ seconds

Two Mechanisms of Incomplete Exhalation

---

3. Causes / Risk Factors

---

4. Detection & Measurement

Bedside Clinical Signs

• Expiratory flow on the flow-time waveform does not return to zero before the next breath (most sensitive continuous sign)
• Unexpectedly ↑ peak airway pressures without change in VT (↑ resistance)
• Unexpectedly ↓ apparent compliance (falsely low, because total PEEP is underestimated)
• Hypotension — especially after intubation
• Failure to trigger — patient makes efforts but ventilator does not register them (ineffective efforts)
• Tachycardia, agitation in a spontaneously breathing patient "fighting" the ventilator

Gold Standard: End-Expiratory Hold Maneuver

1. Patient must be passive (no spontaneous breathing effort)
2. Press expiratory hold button on the ventilator
3. Airway is occluded at end-expiration → alveolar, central airway, and circuit pressure equilibrate
4. Read the pressure displayed on the manometer

Dynamic Hyperinflation Volume

• Prolonged expiration (20–30 seconds to atmosphere) → volume of additional gas released = degree of dynamic hyperinflation

Unreliable in Spontaneously Breathing Patients

• Expiratory hold requires complete passivity; spontaneous efforts during the hold falsely lower the measured value
• Ineffective triggering efforts (>10% of breaths in ~25% of PSV patients) suggest significant auto-PEEP

---

5. Consequences

Hemodynamic

"Auto-PEEP and the attendant dynamic hyperinflation increase pleural pressure and right atrial pressure, thereby leading to a decrease in the driving pressure for venous return. This can be magnified immediately after intubation because compensatory mechanisms are impaired by pharmacologic agents used for intubation." — Goldman-Cecil Medicine

Respiratory

---

6. Management

Immediate / Emergency (Hemodynamic Collapse)

"If hypotension occurs, disconnect the patient from the ventilator for 15–20 seconds" — allows complete exhalation, immediate relief of dynamic hyperinflation → BP recovers

Ventilator Setting Adjustments

"Increasing the respiratory rate is counterproductive because it shortens the exhalation time, leading to an additional breath prior to the lungs completely emptying." — Tintinalli's Emergency Medicine

Pharmacologic

External PEEP to Counteract Auto-PEEP (in spontaneously breathing patients)

• Reduces inspiratory trigger work without adding to end-expiratory lung volume
• Rule: Set external PEEP ≤ 75–85% of measured iPEEP
• Do not apply external PEEP exceeding iPEEP — this will increase EELV and worsen hyperinflation

"Theoretically, for the spontaneously breathing patient, extrinsic PEEP applied to counteract intrinsic PEEP should not cause an increase in EELV until extrinsic PEEP exceeds intrinsic PEEP." — Miller's Anesthesia, 10th ed.

---

7. Auto-PEEP in COPD / Asthma — Specific Approach

---

8. Summary